Viewing nowCombinationAmstel Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
IQUR Co., Ltd.

MFDS item code 201605745 · Approved 2016.09.30 · Insurance code 674401350
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively manage and control blood pressure when telmisartan or amlodipine monotherapy does not sufficiently control blood pressure due to essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components, switching directly to this medication may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medication 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medication 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
○ Pediatric patients: The safety and efficacy of this medication have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This drug can cause serious harm to the fetus, especially in the second and third trimesters of pregnancy; therefore, it should not be taken by women who are pregnant or may become pregnant. This drug should not be administered to patients with certain conditions, such as severe liver impairment, biliary obstruction, severe hypotension, or severely impaired cardiac function. Patients with primary aldosteronism or aortic stenosis, as well as those with obstructive hypertrophic cardiomyopathy, should use this drug cautiously, and patients with liver impairment should also take it with care. Patients with gastrointestinal diseases should be cautious while taking this medication due to the risk of gastrointestinal bleeding. Patients with impaired kidney function, dialysis patients, or elderly individuals should be carefully monitored for potential worsening of kidney function or adverse effects when taking this medication. This drug lowers blood pressure, which may cause hypotensive symptoms, and side effects like dizziness or drowsiness; hence caution is advised when driving or operating machinery. Additionally, this drug may interact with certain medications, so it is essential to consult a physician or pharmacist if you are taking other medications. It is advisable for nursing women not to take this medication; if pregnant or planning to become pregnant, consultation with healthcare professionals is necessary. In case of overdose, severe symptoms such as hypotension and arrhythmia may occur, requiring immediate medical attention. This medication is not recommended for children as safety and efficacy in this patient population have not been sufficiently established.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light and should be stored in a light-proof container. It is also important to keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the drug's efficacy.
White and light blue, double convex oval bilayer tablet.
30 tablets (10 tablets/PTP*3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
IQUR Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.